These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 25144382)
1. Size and surface functionalization of iron oxide nanoparticles influence the composition and dynamic nature of their protein corona. Ashby J; Pan S; Zhong W ACS Appl Mater Interfaces; 2014 Sep; 6(17):15412-9. PubMed ID: 25144382 [TBL] [Abstract][Full Text] [Related]
2. Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages. Vogt C; Pernemalm M; Kohonen P; Laurent S; Hultenby K; Vahter M; Lehtiö J; Toprak MS; Fadeel B PLoS One; 2015; 10(10):e0129008. PubMed ID: 26444829 [TBL] [Abstract][Full Text] [Related]
3. Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. Sakulkhu U; Maurizi L; Mahmoudi M; Motazacker M; Vries M; Gramoun A; Ollivier Beuzelin MG; Vallée JP; Rezaee F; Hofmann H Nanoscale; 2014 Oct; 6(19):11439-50. PubMed ID: 25154771 [TBL] [Abstract][Full Text] [Related]
4. Bio-identity and fate of albumin-coated SPIONs evaluated in cells and by the C. elegans model. Yu SM; Gonzalez-Moragas L; Milla M; Kolovou A; Santarella-Mellwig R; Schwab Y; Laromaine A; Roig A Acta Biomater; 2016 Oct; 43():348-357. PubMed ID: 27427227 [TBL] [Abstract][Full Text] [Related]
5. Protein Corona Formation on Magnetite Nanoparticles: Effects of Culture Medium Composition, and Its Consequences on Superparamagnetic Nanoparticle Cytotoxicity. Mbeh DA; Javanbakht T; Tabet L; Merhi Y; Maghni K; Sacher E; Yahia LH J Biomed Nanotechnol; 2015 May; 11(5):828-40. PubMed ID: 26349395 [TBL] [Abstract][Full Text] [Related]
6. Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sakulkhu U; Mahmoudi M; Maurizi L; Salaklang J; Hofmann H Sci Rep; 2014 May; 4():5020. PubMed ID: 24846348 [TBL] [Abstract][Full Text] [Related]
7. Crucial role of the protein corona for the specific targeting of nanoparticles. Mahmoudi M; Sheibani S; Milani AS; Rezaee F; Gauberti M; Dinarvand R; Vali H Nanomedicine (Lond); 2015 Jan; 10(2):215-26. PubMed ID: 25600967 [TBL] [Abstract][Full Text] [Related]
8. Dissociation-based screening of nanoparticle-protein interaction via flow field-flow fractionation. Ashby J; Schachermeyer S; Pan S; Zhong W Anal Chem; 2013 Aug; 85(15):7494-501. PubMed ID: 23859073 [TBL] [Abstract][Full Text] [Related]
9. Compact zwitterion-coated iron oxide nanoparticles for biological applications. Wei H; Insin N; Lee J; Han HS; Cordero JM; Liu W; Bawendi MG Nano Lett; 2012 Jan; 12(1):22-5. PubMed ID: 22185195 [TBL] [Abstract][Full Text] [Related]
10. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964 [TBL] [Abstract][Full Text] [Related]
11. Protein corona on magnetite nanoparticles and internalization of nanoparticle-protein complexes into healthy and cancer cells. Jiang W; Lai K; Wu Y; Gu Z Arch Pharm Res; 2014 Jan; 37(1):129-41. PubMed ID: 24310098 [TBL] [Abstract][Full Text] [Related]
12. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake. Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541 [TBL] [Abstract][Full Text] [Related]
13. Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. Jansch M; Stumpf P; Graf C; Rühl E; Müller RH Int J Pharm; 2012 May; 428(1-2):125-33. PubMed ID: 22342465 [TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351 [TBL] [Abstract][Full Text] [Related]
15. Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Jedlovszky-Hajdú A; Bombelli FB; Monopoli MP; Tombácz E; Dawson KA Langmuir; 2012 Oct; 28(42):14983-91. PubMed ID: 23002920 [TBL] [Abstract][Full Text] [Related]
16. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Huang Y; Mao K; Zhang B; Zhao Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953 [TBL] [Abstract][Full Text] [Related]
17. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. Mahmoudi M; Shokrgozar MA; Sardari S; Moghadam MK; Vali H; Laurent S; Stroeve P Nanoscale; 2011 Mar; 3(3):1127-38. PubMed ID: 21210042 [TBL] [Abstract][Full Text] [Related]
18. Glutathione-coated luminescent gold nanoparticles: a surface ligand for minimizing serum protein adsorption. Vinluan RD; Liu J; Zhou C; Yu M; Yang S; Kumar A; Sun S; Dean A; Sun X; Zheng J ACS Appl Mater Interfaces; 2014 Aug; 6(15):11829-33. PubMed ID: 25029478 [TBL] [Abstract][Full Text] [Related]
19. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake. Pustulka SM; Ling K; Pish SL; Champion JA ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178 [TBL] [Abstract][Full Text] [Related]
20. Significance of cell "observer" and protein source in nanobiosciences. Laurent S; Burtea C; Thirifays C; Rezaee F; Mahmoudi M J Colloid Interface Sci; 2013 Feb; 392():431-445. PubMed ID: 23141702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]